SCHEMBL5086027

SCHEMBL5086027

NC(=O)Oc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9212257 0.84 ALDH1A1 (0.39)
SCHEMBL28140898 0.83
SCHEMBL27852103 0.83 ALDH1A1 (0.43)
SCHEMBL27478065 0.83 ALDH1A1 (0.43)
SCHEMBL3559527 0.79
SCHEMBL3074508 0.79
SCHEMBL1633629 0.79
SCHEMBL1219078 0.79 PKM (0.38)
SCHEMBL4755861 0.79 ALDH1A1 (0.38)
SCHEMBL27979962 0.79 L3MBTL1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106518858-A Substituted benzothiazole diaryl urea compounds, and preparation method and medical application thereof 中国人民解放军军事医学科学院毒物药物研究所 2017-03-22 CN claimed
WO-2008091594-A2 FUNGICIDAL MIXTURES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-07-31 WO claimed
US-12486289-B2 Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof THE BROAD INSTITUTE, INC. (US) 2025-12-02 US disclosed
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
CN-119638687-A Aromatic heterocyclic pyrrolidones and uses thereof 杭州百新生物医药科技有限公司 2025-03-18 CN disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed
EP-3606528-B1 TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF BROAD INST INC (US) 2023-10-18 EP disclosed
CN-116670136-A Tetracyclic compound and medical application thereof 正大天晴药业集团股份有限公司 2023-08-29 CN disclosed
CN-110958882-B Tricyclic compounds as glycogen synthase kinase 3 (GSK 3) inhibitors and uses thereof 布罗德研究所股份有限公司 2023-08-29 CN disclosed
CN-115201485-A Methods of measuring KRAS protein inhibition 百济神州(北京)生物科技有限公司 2022-10-18 CN disclosed
US-20220112216-A1 TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2022-04-14 US disclosed
EP-1601685-A1 HEPATITIS C INHIBITING COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2005-12-07 EP disclosed
US-6919423-B2 Hepatitis C inhibitor compound BOEHRINGER INGELHEIM INTERNATIONAL, GMBH (DE) 2005-07-19 US disclosed
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates MITSUI CHEMICALS, INC. (JP) 2005-06-30 US disclosed
EP-1489073-A1 PROCESS FORPREPARATION OF ALKOXYBENZAMIDES AND THIAZOLYL ISOCYANATES MITSUI CHEMICALS, INC. (JP) 2004-12-22 EP disclosed
WO-2004101605-A1 HEPATITIS C INHIBITING COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-11-25 WO disclosed
US-20040229818-A1 Hepatitis C inhibitor compound BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-11-18 US disclosed
CN-1374955-A Oxazole and thiazole derivatives as antidiabetic and antiobesity agents BRISTOL MYERS SQUIBB CO (US) 2002-10-16 CN disclosed
US-4987196-A FROM NATURAL RUBBER LATEX THE YOKOHAMA RUBBER CO., LTD. (JP) 1991-01-22 US disclosed
US-3825552-A THIAZOLE CARBAMATE PESTICIDES E.I. DU PONT DE NEMOURS AND COMPANY 1974-07-23 US disclosed